# Foghorn Therapeutics Inc.: Form 8-K, filed Apr 24, 2023

- Company: [Foghorn Therapeutics Inc.](/companies/fhtx.md) (CIK 1822462)
- Form: 8-K
- Filed: 2023-04-24
- Accepted by EDGAR: Apr 24, 2023, 11:05 ET
- Period: 2023-04-24
- Accession: 0001628280-23-012499
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1822462/000162828023012499/fhtx-20230424.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1822462/000162828023012499/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1822462/000162828023012499/fhtx-20230424.htm

Filed Apr 24, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-012499. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
